MediGene and Will-Pharma Sign Agreement for the Commercialization of Veregen in Benelux
15-Mar-2011
- Belgium
MediGene has already entered into several marketing partnerships for Veregen®, e.g. with Nycomed for the USA, with Abbott for Germany, Austria, and Switzerland, with Expanscience for France, with Juste for Spain and Portugal as well as with a number of other partners across Europe, Latin America and Asia. MediGene is planning to continue this global licensing strategy.
Most read news
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.